Biocept, Inc.
BIOC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13 | $29 | $14 | $9 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $14 | $14 | $4 |
| Inventory | $1 | $3 | $2 | $1 |
| Other Curr. Assets | $1 | $0 | $2 | $0 |
| Total Curr. Assets | $16 | $46 | $33 | $14 |
| Property Plant & Equip (Net) | $14 | $14 | $14 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | -$4 |
| Total NC Assets | $15 | $15 | $15 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $31 | $60 | $47 | $18 |
| Liabilities | – | – | – | – |
| Payables | $2 | $7 | $8 | $2 |
| Short-Term Debt | $2 | $2 | $1 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $3 | $3 | $2 |
| Total Curr. Liab. | $6 | $12 | $12 | $6 |
| LT Debt | $10 | $11 | $11 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $0 | $0 | $0 |
| Total NC Liab. | $17 | $11 | $11 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $22 | $23 | $24 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$298 | -$266 | -$264 | -$246 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $307 | $304 | $287 | $257 |
| Total Equity | $9 | $37 | $24 | $11 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $31 | $60 | $47 | $18 |
| Net Debt | -$1 | -$16 | -$2 | -$7 |